New study tracks immune effects of Long-Term NMOSD drug
NCT ID NCT06180278
First seen Nov 21, 2025 · Last updated May 12, 2026 · Updated 19 times
Summary
This study looks at the long-term safety of inebilizumab, a drug for neuromyelitis optica spectrum disorder (NMOSD). It measures how the drug affects immune cells and antibody levels over time, and what happens when treatment stops. The study involves 32 adults who have already been on the drug for at least 2 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROMYELITIS OPTICA SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine
Houston, Texas, 77030-4202, United States
-
Khon Kaen University, Srinagarind Hospital - Division of Neurology, Depart
Khon Kaen, 40002, Thailand
-
M.A.-Lek A.M. Maciejowscy S.C. Centrum Terapii SM
Katowice, Silesian Voivodeship, 40-751, Poland
-
National Cancer Center - Neurology Clinic
Goyang-si, Gyeonggido [Kyonggi-do], 10408, South Korea
-
Prince of Wales Hospital (PWH) - The Chinese University of Hong Kong (CUHK) - Ophtalmology
Hong Kong, 0000, China
-
Samsung Medical Center - Pediatric Neurology
Seoul, Seoul Teugbyeolsi [Seoul-T'ukp, 6351, South Korea
-
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi [Seoul-T'ukp, 03080, South Korea
-
Szegedi Tudományegyetem, à OK, Szent-Györgyi Albert Klinikai Központ - Neurológiai Osztály
Szeged, Csongrád megye, 6725, Hungary
-
Uniwersyteckie Centrum Kliniczne WUM - Oddzial Kliniczny Neurologii
Warsaw, Masovian Voivodeship, 02-057, Poland
-
Vseobecna fakultni nemocnice v Praze - Neurologicka klinika
Prague, 128 21, Czechia
-
Wayne State University School of Medicine
Detroit, Michigan, 48201-2153, United States
Conditions
Explore the condition pages connected to this study.